The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces differentiation and apoptosis in human leukemia K562 cells
収録刊行物
-
- Mol. Pharmacol.
-
Mol. Pharmacol. 59 453-461, 2001